NUS Historical Income Statement

NUS Stock

USD 12.01 0.04 0.33%

Historical analysis of Nu Skin income statement accounts such as Gross Profit of 1.4 B can show how well Nu Skin Enterprises performed in making a profits. Evaluating Nu Skin income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Nu Skin's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Nu Skin Enterprises latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nu Skin Enterprises is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

About NUS Income Statement Analysis

Nu Skin Enterprises Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Nu Skin shareholders. The income statement also shows NUS investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Nu Skin Income Statement Chart

Nu Skin Enterprises Income Statement is one of the three primary financial statements used for reporting NUS's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Nu Skin Enterprises revenue and expense. Nu Skin Income Statement primarily focuses on the company's revenues and expenses during a particular period.

At this time, Nu Skin's Interest Expense is comparatively stable compared to the past year. Gross Profit is likely to gain to about 1.4 B in 2024, whereas Total Revenue is likely to drop slightly above 1.8 B in 2024.

Total Revenue Gross Profit Other Operating Expenses Operating Income

Total Revenue

Total revenue comprises all receipts Nu Skin Enterprises generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Nu Skin Enterprises minus its cost of goods sold. It is profit before Nu Skin operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Nu Skin Enterprises. It is also known as Nu Skin overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Nu Skin Enterprises operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Nu Skin Enterprises is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Nu Skin's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Nu Skin Enterprises current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

	2021	2022	2023	2024 (projected)
Gross Profit	2.0B	1.6B	1.4B	1.4B
Total Revenue	2.7B	2.2B	2.0B	1.8B

Gross Profit Total Revenue

Nu Skin income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Research Development	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Minority Interest	Reconciled Depreciation	Extraordinary Items	Non Recurring
Depreciation And Amortization		0.36	0.58	0.44	0.68	-0.11	-0.1	0.08	0.9	0.54	-0.11	-0.04	-0.08	-0.14	0.56	0.9	0.31	-0.31	-0.18	-0.11	0.51	0.08	0.4	0.01	-0.46
Interest Expense	0.36		-0.05	-0.16	0.04	-0.61	-0.59	-0.42	0.34	-0.08	-0.58	0.01	-0.49	-0.65	0.06	0.39	-0.19	-0.5	-0.01	-0.81	0.48	-0.66	-0.32	0.65	-0.97
Total Revenue	0.58	-0.05		0.98	0.99	0.69	0.69	0.82	0.79	1.0	0.66	0.05	0.66	0.6	0.7	0.66	0.93	0.47	0.01	0.18	0.19	0.22	0.35	-0.19	-0.04
Gross Profit	0.44	-0.16	0.98		0.95	0.8	0.8	0.9	0.66	0.99	0.77	0.06	0.75	0.71	0.64	0.54	0.97	0.59	0.03	0.26	0.07	0.24	0.29	-0.25	0.09
Other Operating Expenses	0.68	0.04	0.99	0.95		0.59	0.59	0.73	0.86	0.98	0.57	0.02	0.57	0.5	0.71	0.74	0.88	0.37	-0.03	0.11	0.26	0.18	0.37	-0.12	-0.13
Operating Income	-0.11	-0.61	0.69	0.8	0.59		1.0	0.94	0.15	0.72	0.98	0.14	0.95	0.93	0.33	0.02	0.83	0.9	0.19	0.56	-0.38	0.49	0.22	-0.49	0.56
Ebit	-0.1	-0.59	0.69	0.8	0.59	1.0		0.95	0.15	0.72	0.98	0.14	0.95	0.92	0.35	0.03	0.83	0.9	0.18	0.54	-0.4	0.48	0.2	-0.48	0.54
Ebitda	0.08	-0.42	0.82	0.9	0.73	0.94	0.95		0.31	0.84	0.91	0.06	0.87	0.87	0.49	0.2	0.94	0.79	0.12	0.41	-0.26	0.28	0.1	-0.39	0.36
Cost Of Revenue	0.9	0.34	0.79	0.66	0.86	0.15	0.15	0.31		0.75	0.14	0.0	0.17	0.07	0.7	0.89	0.55	-0.03	-0.07	-0.11	0.51	0.1	0.46	0.08	-0.46
Total Operating Expenses	0.54	-0.08	1.0	0.99	0.98	0.72	0.72	0.84	0.75		0.69	0.02	0.68	0.62	0.66	0.63	0.94	0.49	-0.01	0.19	0.15	0.21	0.31	-0.18	0.0
Income Before Tax	-0.11	-0.58	0.66	0.77	0.57	0.98	0.98	0.91	0.14	0.69		0.34	0.98	0.93	0.33	0.07	0.79	0.93	0.3	0.61	-0.33	0.54	0.29	-0.55	0.53
Total Other Income Expense Net	-0.04	0.01	0.05	0.06	0.02	0.14	0.14	0.06	0.0	0.02	0.34		0.37	0.24	0.07	0.23	0.04	0.39	0.62	0.38	0.15	0.39	0.37	-0.41	-0.02
Net Income	-0.08	-0.49	0.66	0.75	0.57	0.95	0.95	0.87	0.17	0.68	0.98	0.37		0.82	0.32	0.08	0.78	0.95	0.32	0.49	-0.32	0.58	0.29	-0.58	0.44
Income Tax Expense	-0.14	-0.65	0.6	0.71	0.5	0.93	0.92	0.87	0.07	0.62	0.93	0.24	0.82		0.32	0.03	0.73	0.79	0.25	0.73	-0.33	0.43	0.26	-0.43	0.61
Selling General Administrative	0.56	0.06	0.7	0.64	0.71	0.33	0.35	0.49	0.7	0.66	0.33	0.07	0.32	0.32		0.63	0.68	0.25	-0.09	0.15	0.4	0.08	0.43	-0.13	-0.22
Research Development	0.9	0.39	0.66	0.54	0.74	0.02	0.03	0.2	0.89	0.63	0.07	0.23	0.08	0.03	0.63		0.43	-0.12	-0.08	-0.03	0.61	0.06	0.39	0.04	-0.47
Selling And Marketing Expenses	0.31	-0.19	0.93	0.97	0.88	0.83	0.83	0.94	0.55	0.94	0.79	0.04	0.78	0.73	0.68	0.43		0.67	0.05	0.23	0.01	0.18	0.2	-0.25	0.12
Net Income From Continuing Ops	-0.31	-0.5	0.47	0.59	0.37	0.9	0.9	0.79	-0.03	0.49	0.93	0.39	0.95	0.79	0.25	-0.12	0.67		0.38	0.46	-0.4	0.51	0.19	-0.51	0.46
Non Operating Income Net Other	-0.18	-0.01	0.01	0.03	-0.03	0.19	0.18	0.12	-0.07	-0.01	0.3	0.62	0.32	0.25	-0.09	-0.08	0.05	0.38		0.2	-0.1	0.14	0.1	-0.14	-0.05
Tax Provision	-0.11	-0.81	0.18	0.26	0.11	0.56	0.54	0.41	-0.11	0.19	0.61	0.38	0.49	0.73	0.15	-0.03	0.23	0.46	0.2		-0.3	0.69	0.51	-0.7	0.74
Interest Income	0.51	0.48	0.19	0.07	0.26	-0.38	-0.4	-0.26	0.51	0.15	-0.33	0.15	-0.32	-0.33	0.4	0.61	0.01	-0.4	-0.1	-0.3		-0.27	0.36	0.28	-0.47
Minority Interest	0.08	-0.66	0.22	0.24	0.18	0.49	0.48	0.28	0.1	0.21	0.54	0.39	0.58	0.43	0.08	0.06	0.18	0.51	0.14	0.69	-0.27		0.71	-0.8	0.58
Reconciled Depreciation	0.4	-0.32	0.35	0.29	0.37	0.22	0.2	0.1	0.46	0.31	0.29	0.37	0.29	0.26	0.43	0.39	0.2	0.19	0.1	0.51	0.36	0.71		-0.44	0.22
Extraordinary Items	0.01	0.65	-0.19	-0.25	-0.12	-0.49	-0.48	-0.39	0.08	-0.18	-0.55	-0.41	-0.58	-0.43	-0.13	0.04	-0.25	-0.51	-0.14	-0.7	0.28	-0.8	-0.44		-0.61
Non Recurring	-0.46	-0.97	-0.04	0.09	-0.13	0.56	0.54	0.36	-0.46	0.0	0.53	-0.02	0.44	0.61	-0.22	-0.47	0.12	0.46	-0.05	0.74	-0.47	0.58	0.22	-0.61

Click cells to compare fundamentals

Nu Skin Account Relationship Matchups

Nu Skin income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	76.7M	74.0M	103.7M	97.0M	69.6M	49.6M
Interest Expense	19.2M	13.1M	11M	21.9M	25.2M	26.4M
Total Revenue	2.4B	2.6B	2.7B	2.2B	2.0B	1.8B
Gross Profit	1.8B	1.9B	2.0B	1.6B	1.4B	1.4B
Other Operating Expenses	2.2B	2.3B	2.4B	2.1B	1.9B	1.6B
Operating Income	190.8M	257.6M	234.0M	110.8M	68.1M	64.7M
Ebit	190.8M	257.6M	234.0M	110.8M	68.1M	64.7M
Ebitda	267.4M	331.6M	337.7M	207.8M	137.7M	247.0M
Cost Of Revenue	581.4M	658.0M	675.2M	630.9M	611.9M	377.1M
Total Operating Expenses	1.6B	1.7B	1.7B	1.4B	1.3B	1.2B
Income Before Tax	255.2M	256.2M	232.5M	89.0M	26.6M	25.2M
Total Other Income Expense Net	64.4M	(1.3M)	(1.5M)	(21.9M)	(41.5M)	(39.4M)
Net Income	173.6M	191.4M	147.3M	104.8M	8.6M	8.2M
Income Tax Expense	81.6M	64.9M	85.2M	(15.8M)	18.0M	17.1M
Selling General Administrative	616.0M	646.8M	666.4M	555.8M	546.9M	570.7M
Net Income Applicable To Common Shares	173.6M	191.4M	147.3M	104.8M	120.5M	135.7M
Research Development	23M	30.1M	23.3M	27.2M	22.6M	18.1M
Selling And Marketing Expenses	955.6M	1.0B	1.1B	879.6M	742.4M	888.3M
Net Income From Continuing Ops	173.6M	191.4M	147.3M	104.8M	58.5M	55.6M
Non Operating Income Net Other	(12.3M)	(1.3M)	(1.5M)	(21.9M)	(19.7M)	(20.7M)
Tax Provision	81.6M	64.9M	85.2M	(15.8M)	(16.9M)	(16.1M)
Interest Income	19.2M	13.1M	11M	13.5M	15.5M	15.1M
Reconciled Depreciation	76.7M	74.0M	76.3M	72.5M	70.9M	60.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Nu Skin Enterprises is a strong investment it is important to analyze Nu Skin's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nu Skin's future performance. For an informed investment choice regarding NUS Stock, refer to the following important reports:

How To Invest In NUS

Details

Is NUS Stock a good investment?

Details

What is Nu Skin's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for NUS Stock analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.

	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Commodity Directory Find actively traded commodities issued by global exchanges
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments

Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.88)

Dividend Share

1.56

Earnings Share

0.17

Revenue Per Share

39.612

Quarterly Revenue Growth

(0.07)

The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

NUS Historical Income Statement

About NUS Income Statement Analysis

Nu Skin Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

Nu Skin income statement Correlations

Nu Skin Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nu Skin income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for NUS Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Total Revenue
Ebit	+ 1.0	Operating Income
Other Operating Expenses	+ 0.99	Total Revenue
Total Operating Expenses	+ 0.99	Gross Profit
Gross Profit	+ 0.98	Total Revenue
Total Operating Expenses	+ 0.98	Other Operating Expenses

Non Recurring	- 0.97	Interest Expense
Tax Provision	- 0.81	Interest Expense
Extraordinary Items	- 0.8	Minority Interest
Extraordinary Items	- 0.7	Tax Provision
Minority Interest	- 0.66	Interest Expense
Income Tax Expense	- 0.65	Interest Expense